Through exome sequencing, it was observed that 79% of the lesions (EC and/or DIE) had mutations, and 26% of these were found in the ARID1A, PIK3CA, KRAS, and PPP2R1A genes, where PIK3CA and KRAS are genes frequently mutated in ovarian cancer. The gene discussed is KRAS; the disease is ovarian cancer.